References
Taylor KM, Morton IJ, Brown JJ, Bain WH, Caves PK. Hypertension and the renin-angiotensin system following open heart surgery. Journal of Thoracic and Cardiovascular Surgery 1977; 74: 840–5.
Estafanous FG, Tarazi RC, Viljoen JF, Tawil MY. Systemic hypertension following myocardial revascularisation. American Heart Journal 1973; 85: 732–8.
Roberts AJ, Niarchos AP, Subramanian VA, Abel RM, Herman SD, Sealey JE, Case DA, White RP, Johnson GA, Laragh JH, Gay WA Jr. Systemic hypertension associated with coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery 1977; 74: 846–59.
Estafanous FG, Tarazi RC. Systemic hypertension associated with cardiac surgery. The American Journal of Cardiology 1980; 46: 685–94.
Wallach R, Karp RB, Reves JG et al. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: A study of hemodynamic and humoral factors. The American Journal of Cardiology 1980; 46: 559–65.
Chiariello M, Gold HK, Leinbach RC, Davis MA, Maroko PR. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 1976; 54: 766–73.
Becket LC. Conditions for vasodilator induced coronary artery steal in experimental myocardial ischemia. Circulation 1978; 57: 1103–10.
Colley PS, Cheney FW. Sodium nitroprusside increases Qs/Qt in dogs with regional atelectasis. Anesthesiology 1977;47: 338–41.
Azar I, Turndoff H. Intravenous nitroglycerin and pulmonary shunting after coronary artery bypass operation. American Review of Respiratory Disease 1979; 119: Suppl. 92.
Michenfelder JD. Cyanide release from sodium nitroprusside in the dog. Anesthesiology 1977; 46: 196–201.
Ivankovitch AD, Miletich DJ, Tinker JH. Sodium nitroprusside: Metabolism and general considerations. International Anesthesiology Clinics 1978; 16: 1–29.
Brown RA, Dixon J, Farmer JB, Hall JL, Humphries RL, Ince F, O’Connor SE, Simpson WT, Smith GW. Dopexamine: A novel agonist at peripheral dopamine receptors and β2-adrenoceptors. British Journal of Pharmacology 1985; 599–600.
Magrini F, Foulds R, Roberts N, Macchi G, Mondadori C, Zanchetti H. Human renovascular effects of dopexamine hydrochloride; A novel agonist at peripheral dopamine and beta-2 adrenoreceptors. European Journal of Clinical Pharmacology 1987; 32(1): 1–4.
Mitchell PD, Smith GW, Wells E, West PA. Inhibition of Uptake-1 by dopexamine hydrochloride (in vitro). British Journal of Pharmacology 1987; 92: 265–70.
Jaski BE, Wijns W, Foulds SR, Serruys PW. The haemodynamic and myocardial effects of dopexamine; a new β2-adrenoceptor agonist. British Journal of Clinical Pharmacology 1986; 21: 393–400.
Neale MG, Baker P, Brown K, Foulds RA, Morris DA. Pharmacokinetics and metabolism of dopexamine in man. Acta Pharmacologica Toxicology 1986; 59(55): 69.
Tan LB, Littler W, Murray RG. Beneficial haemodynamic effects of intravenous dopexamine in patients with lowoutput heart failure. Journal of Cardiovascular Pharmacology 1987; 10: 280–6.
Dawson JR, Thomson DS, Signy M, Jvul SM, Turnbull P, Jenkins BS, Webb-Peploe MM. Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure. British Heart Journal 1985; 54: 313–20.
Svensson G, Sjögren A, Erhardt L. Short term haemodynamic effects of dopexamine in patients with chronic heart failure. European Heart Journal 1986; 7(8): 697–703.
Colvin JR, Kenny GNC. Development and evaluation of a dual-pump microcomputer-based closed loop arterial pressure control system. International Journal of Clinical Monitoring and Computing, 1989; 6: 31–5.
Colvin JR, Kenny GNC. Automatic Control of arterial pressure after cardiac surgery: Evaluation of a microcomputer-based control system using glyceryl trinitrate and sodium nitroprusside. In press.
Chaudhri S, Kenny GNC. The nitroprusside sparing effect of enoximone. In press.
Sheppard LC, Shotts JF, Robertson NF, Wallace FD, Kouchoukos NT. Computer controlled infusion of vasoactive drugs in post-cardiac surgical patients. The New York State Society of Anesthesiologists Inc. 35th Postgraduate Assembly 1981, Dec 12–16.
De Asla RA, Benis AM, Jurado RA, Litwak RS. Management of postcardiotomy hypertension by microcomputer controlled administration of sodium nitroprusside. Journal of Thoracic and Cardiovascular Surgery 1985; 89: 115–20.
Reid JA, Kenny GNC. Evaluation of closed loop control of arterial pressure after cardiopulmonary bypass. British Journal of Anaesthesia 1987; 59: 247–55.
Hodsman NBA, Colvin JR, Kenny GNC. The effect of ketanserin on sodium nitroprusside requirements, blood pressure control and heart rate following coronary artery bypass surgery. British Journal of Anaesthesia. In press.
Gollub SB, Emmot WW, Johnson DE, Sights KA, Wilson DB, Vacek JL, Hassanein K. Haemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours duration for severe congestive heart failure. American Journal of Cardiology 1988; 62: 83C-88C.
Van der Starre PJA, Rosseel PMJ. Dopexamine hydrochloride after coronary artery bypass grafting. American Journal of Cardiology 1988; 62(5): 78C-82C.
Van der Starre PJA, Scheijgrond HW, Reneman RS, Kolling JB. The use of ketanserin, a 5-OHT receptor antagonist for treatment of postoperative hypertension following coronary artery bypass surgery. Anaesthesia and Analgesia 1983; 62: 63–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colvin, J.R., Chaudhri, S. & Kenny, G.N.C. Evaluation of dopexamine hydrochloride as an anti-hypertensive agent after cardiac surgery. J Clin Monit Comput 8, 95–100 (1991). https://doi.org/10.1007/BF02915542
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02915542